Location History:
- Palatine, IL (US) (1976 - 1977)
- McHenry, IL (US) (1982 - 1995)
- Barrington, IL (US) (1999 - 2000)
Company Filing History:
5 out of 809 
3 out of 2,483 
Years Active: 1976-2000
Title: Jan W Garber: Innovator in Hemoglobin Therapy
Introduction
Jan W Garber is a notable inventor based in Barrington, IL (US), recognized for her contributions to medical innovations, particularly in the field of hemoglobin therapy. With a total of 8 patents, her work has significantly impacted the treatment of patients undergoing hemodialysis.
Latest Patents
One of her latest patents focuses on hemoglobin therapy in hemodialysis. In this innovative approach, low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients. This method aims to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Furthermore, when implemented prophylactically, this therapy partially obviates the need for further interventions to control circulatory system instability.
Career Highlights
Throughout her career, Jan has worked with prominent companies such as Baxter Travenol Laboratories, Inc. and Baxter International Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas in medical therapies.
Collaborations
Jan has collaborated with esteemed colleagues, including De Wayne Davisson and Henry M Gajewski. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Jan W Garber's work in hemoglobin therapy represents a significant advancement in medical treatment for hemodialysis patients. Her innovative approach and dedication to improving patient care continue to inspire future developments in the field.